Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 Trial.

Saved in:
Bibliographic Details
Title: Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 Trial.
Authors: Horn DB; University of Texas Center for Obesity Medicine and Metabolic Performance, Department of Surgery, McGovern Medical School, Houston., Linetzky B; Eli Lilly and Company, Indianapolis, Indiana., Davies MJ; Diabetes Research Centre, University of Leicester, NIHR Leicester Biomedical Research Centre, Leicester, United Kingdom., Laffin LJ; Cleveland Clinic Foundation, Cleveland, Ohio., Wang H; TechData Service Company, King of Prussia, Pennsylvania., Murphy MA; Eli Lilly and Company, Indianapolis, Indiana., Zimner-Rapuch S; Lilly France, Neuilly-sur-Seine, France., Lau E; Eli Lilly and Company, Lisbon, Portugal., Arad AD; Eli Lilly and Company, Indianapolis, Indiana., Lee CJ; Eli Lilly and Company, Indianapolis, Indiana.
Source: JAMA internal medicine [JAMA Intern Med] 2026 Feb 01; Vol. 186 (2), pp. 157-167.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print Cited Medium: Internet ISSN: 2168-6114 (Electronic) Linking ISSN: 21686106 NLM ISO Abbreviation: JAMA Intern Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2168-6114
DOI:10.1001/jamainternmed.2025.6112